Shanghai Junshi Biosciences Co., Ltd. (SHJBF)

1.8600 0.0000 (0.00%) As of 09:51AM EDT. Market open.

Shanghai Junshi Biosciences Co., Ltd.

Building 7
15th Floor No.6, Lane 100, Pingjiaqiao Road Pudong New Area
Shanghai 200126
China
86 21 6105 8800
https://www.junshipharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2,568

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jun Xiong	Executive Chairman	N/A	N/A	1974
Mr. Cong Li	Co-CEO & Executive Director	N/A	N/A	1964
Dr. Jianjun Zou	GM, CEO & Executive Director	N/A	N/A	1971
Dr. Ning Li	Executive Vice-Chairman of the Board	N/A	N/A	1961
Mr. Baohong Xu	Financial Director	N/A	N/A	1979
Mr. Zhuobing Zhang	Deputy GM & Executive Director	N/A	N/A	1967
Dr. Sheng Yao Ph.D.	Senior VP & Executive Director	N/A	N/A	1975
Dr. Gang Wang	Deputy GM, Chief Quality Officer, Senior VP of Industry Affairs & Executive Director	N/A	N/A	1957
Ms. Yingge Chen	Joint Company Secretary	N/A	N/A	1991
Ms. Lu Yuan	Assistant to GM & Chief of Internal Audit Department	N/A	N/A	1982

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

Corporate governance

Shanghai Junshi Biosciences Co., Ltd.’s ISS governance QualityScore as of 1 April 2024 is 8. The pillar scores are Audit: 7; Board: 9; Shareholder rights: 9; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.